A survey study revealed some factors affecting why U.S. healthcare providers prescribe combination therapy versus monotherapy ...

The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in one healthcare system formulary led to increased healthcare utilization ...

Merck MRK announced a definitive agreement to acquire Verona Pharma VRNA for approximately $10 billion. The deal will add Verona’s Ohtuvayre, approved for the maintenance treatment of chronic ...

In this video, Jeff Yu, MD, MS, highlighted the possible future directions of atopic dermatitis like further development of topical therapies, combination therapies and discussions of ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively increasing symptom burden, exercise limitations, and frequent ...

Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s ...

COPD can be treated with inhalers. Inhalers can contain one, two, or three different medications. These medications include long-acting bronchodilators (LABA and LAMA), which open (dilate) the airways ...

Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying impending exacerbations of COPD.

TUESDAY, July 1, 2025 (HealthDay News) -- Digital inhalers may help predict the occurrence of acute exacerbations of chronic obstructive pulmonary disease (COPD) for patients in an ambulatory setting, ...